Coca-Cola Europacific Partners: A Deep Value Investing Analysis

Hunting ten-year five-baggers among great growth stocks — pressing the upside question: "Can it get much bigger?"

• QHow high is its market ceiling? Is it growing an existing pie, or creating an entirely new market?5/10

  A

  The ceiling is "growing and defending an already very large existing pie," not creating a new market — and this is precisely the first hard constraint that keeps CCEP from fitting Baillie Gifford's "5x in ten years" narrative.

  First, quantify the pie. On its "What we do" page, CCEP describes the soft-drink category across its covered markets as exceeding €175bn, and expects it can still achieve up to roughly 6% annual growth over the next five years. This is a huge, mature, demand-stable pool, but its keyword is "mature" rather than "newborn": across 31 markets CCEP "makes, moves and sells" Coca-Cola system beverages, serving more than 600 million consumers and connecting about 4 million customers, and what it does is sell cola, flavored sparkling drinks, water, sports drinks, RTD tea/coffee, Monster, and Costa in greater volume, at higher prices, and with better mix within fully developed licensed territories, rather than opening up a brand-new track from scratch.

  Which of the two is it doing? The answer is very clear: growing and defending the existing pie. The growth formula is the three-variable interplay the report highlights — "case volume × revenue per case − unit cost": 2025 total volume of about 3.958 billion unit cases, full-year revenue of €20.9bn (reported, +2.3% year over year), implying revenue per case of about €5.38. This is a classic mature-consumer-goods path of "steady volume, rising price, plus mix optimization," rather than disruptive expansion that creates an incremental market. Even the company's brightest current increment — energy drinks, with Energy growing 21.3% in the single quarter of Q1 2026 — is, in essence, grabbing share of the existing sub-category of energy drinks within existing channels, not inventing a new category.

  What Baillie Gifford truly looks for is a name where "the market ceiling is so high it is out of sight, and the company is creating the market." Measured by that yardstick, CCEP's TAM is large but its growth rate is capped in the single digits, and growth relies on penetration and price increases rather than the emergence of new markets. The conclusion is honest: this is an understandable, sustainable good business, but its ceiling is naturally limited, and the roughly 6% industry growth of the soft-drink category is essentially the physical upper bound of its long-term volume-and-price growth. On the "market ceiling / creating a new market" dimension I can only give a neutral-to-weak judgment — the pie is big and stable enough, but not the "infinitely extensible" kind in the Baillie Gifford sense.

  Jun 10, 2026
• QOver the next five years, can its revenue at least double? Is growth driven mainly by volume, price, or new business?3/10

  A

  Almost impossible — doubling revenue over five years (about 15% annualized) far exceeds this business's physical growth rate; growth is driven mainly, and mildly, by "price + mix," with volume as support and M&A as an occasional accelerator, nowhere near doubling magnitude.

  First, calculate what doubling requires. Starting from 2025 reported revenue of €20.9bn, doubling in five years means a compound annual growth of about 14.9%. Yet in the soft-drink category CCEP operates in, the industry ceiling the company itself gives is up to about 6% annual growth over the next five years. The organic growth of a mature bottling business is structurally pressed down by this ceiling, and doubling via internal growth does not hold up mathematically.

  Next, look at what drives growth — this is the core of the question. Broken into three engines:

  • Price/mix (main engine): 2025 revenue per case grew +1.6% year over year; in Q1 2026 revenue per case rose to €5.29 (+0.8%), reflecting price increases, product mix (zero-sugar, small packs, energy drinks), and tax changes. This is CCEP's most stable and most sustainable source of revenue growth, but mild — "able to keep up with inflation, slightly above inflation" rather than raising prices at will (over-pricing bites back into volume).
  • Volume (secondary engine): Q1 2026 total volume of 970M unit cases, reported +8.5%, but a large part came from the accounting effect of M&A consolidation, with Average Daily Sales only +1.6% — after stripping out the accounting effect, real organic volume growth is low single digits, and volumes in parts of Europe still face pressure.
  • New business/M&A (occasional accelerator): what can truly lift revenue in a step change is M&A. In 2024 CCEP and Aboitiz acquired the Philippines business for US$1.8 billion (CCEP holding a 60% stake), and 2025 revenue was significantly boosted by a full year of Philippine consolidation. But M&A is a one-off step, not a sustainable doubling engine, and the subsequent ROIC delivery still needs verification.

  A cross-comparison makes the point even clearer: the faster-growing same-system bottler Coca-Cola HBC had 2025 net sales of €11.6bn with organic growth of only 8.1%, and 2026 organic revenue guidance of 6–7% — even a peer more tilted toward emerging markets cannot reach a doubling pace, and CCEP, larger and in more mature markets, certainly cannot.

  Conclusion first, then close it out: doubling revenue in five years is unrealistic for CCEP. Its growth is a mature-consumer-goods combination of "price + mix as the main driver, organic volume as support, M&A as occasional accelerator," and long-term organic growth most likely lands in the low-to-mid single digits; to achieve a five-year doubling on that, the Baillie Gifford dimension can only be judged weak.

  Jun 10, 2026
• QFive years from now, what will take over as the next growth engine? Does this "second curve" exist today?4/10

  A

  There is no "second curve" in the true sense — CCEP's next leg of growth is an extension of the same main curve (mix upgrades and regional consolidation), rather than an entirely new growth pole that exists today and can independently take over in the future.

  What this Baillie Gifford question seeks is: when the core business growth peaks, is there an independent new curve that has already sprouted today and can carry the growth banner in the future. Honestly viewing CCEP, the answer is essentially no; the few "increments" one can see are all attached to the main curve:

  • Energy drinks and coffee/tea (the most increment-like, but still within-category upgrades): this is the brightest structural increment at present. In Q1 2026, Other (including Energy) grew +9.2% overall, of which Energy alone grew +21.3%, gaining growth through innovation and distribution; the company's portfolio includes Monster and Costa Coffee. But this is, in essence, "selling higher-unit-price adjacent categories within existing channels" — a structural upgrade of the main curve, not a new curve that can grow independently of the Coca-Cola system.
  • Zero-sugar/low-sugar (defensive upgrade, not a growth pole): in Q1 2026 the company again stressed that Coca-Cola Zero Sugar was strong across multiple markets. This maintains the health-oriented vitality of the core category, belonging to "defending the main curve," and hardly counts as a second curve.
  • Regional expansion/M&A (a one-off step, not a curve): the Philippines (a US$1.8 billion acquisition in 2024, CCEP holding a 60% stake) brought a revenue step-up in 2025. But M&A is a discrete one-off event, and CCEP's expansion is bounded by licensed-territory borders — it is a bottler, and new markets depend on obtaining new licensed domains; it cannot freely expand.

  The more fundamental structural constraint lies in the business model itself: CCEP is a bottler in the Coca-Cola system, and its economic-interest ceiling is constrained by the upstream The Coca-Cola Company's brand and concentrate supply. The ability to truly create entirely new categories and new markets rests more in the brand owner's hands than the bottler's. The bottler's role means it can hardly grow out of nowhere a second curve unrelated to its core business.

  Conclusion: the "second curve" does not exist today. CCEP's future growth is still an extension of the same "case volume × revenue per case" main curve — using energy drinks/coffee for mix upgrades and regional M&A for steps. This is a sustainable good business, but measured by Baillie Gifford's "where is the next growth engine" yardstick, it has no exciting successor, and this dimension is judged weak.

  Jun 10, 2026
• QWhat is its core competitive advantage? Will this moat widen or narrow over the next three to five years?6/10

  A

  The core advantage is a four-in-one regionally exclusive bottling platform: "Coca-Cola brand agency rights + scale procurement + localized manufacturing/routing + channel execution"; the moat is real and fairly wide, but over the next three to five years it will most likely be "stable" rather than markedly widening — it can hold, yet, constrained by the upstream brand owner, it is hard to widen indefinitely.

  First, what the moat consists of, item by item grounded in facts:

  • Brand agency rights (strong): regionally exclusive bottling and distribution rights leveraging globally powerful brands such as Coca-Cola, Sprite, Fanta, Monster, and Costa. This is the core, but also the boundary — the brands do not belong to CCEP.
  • Scale (strong): 31 markets, about 4 million customers, 600 million consumers, one of the world's largest independent Coca-Cola bottlers by revenue (2025 reported revenue of €20.9bn, versus same-system Coca-Cola HBC at only €11.6bn); scale itself spreads fixed costs and strengthens procurement and channel density.
  • Localized manufacturing (moderate-to-strong): more than 90% of the beverages sold are produced locally in the country of consumption, forming a high-entry-barrier manufacturing + logistics + cold-chain network.
  • Channel execution (strong): on-time supply, shelf merchandising, cooler placement, point-of-sale promotional execution — retailers have low switching costs but high stickiness of channel resources.
  • Network effects (weak/none), patent barriers (ordinary): consumers can switch beverages at any time; the moat comes not from network effects or patents but from licensed territories and system relationships.

  The objective evidence of moat strength is the delivery of pricing power and returns: 2025 revenue per case +1.6%, Q1 2026 revenue per case rising to €5.29, and 2025 comparable ROIC reaching 11.5% — showing it can indeed manage prices in mature markets and turn the moat into cash returns.

  Will it widen or narrow over the next three to five years? I judge it stable, viewing both sides: the defensible side — strong brands, the localized network, and channel execution are structural in mature markets; sugar taxes and health preferences merely "slowly reshape" rather than disrupt, and the company keeps iterating across multiple price tiers such as zero-sugar, energy, and coffee. The hard-to-widen side — its economic-interest ceiling is sealed by the upstream Coca-Cola system (the bottling end's profit ceiling is naturally lower than the brand/concentrate end), and growth is built on penetration and price increases rather than new barriers; volumes in parts of Europe are under pressure, and Indonesia was hit by a multi-country brand boycott triggered by Middle East events.

  Conclusion: the moat is real, fairly wide, and defensible, but not the kind that keeps widening. Its width is determined by the Coca-Cola system's licensing boundaries; CCEP can consolidate its execution but can hardly break through the ceiling set upstream. On this Baillie Gifford dimension, the moat itself earns a positive assessment, but the room to imagine "future widening" is limited.

  Jun 10, 2026
• QIf the core business is disrupted, does it have the DNA for self-reinvention? How does it treat mistakes and bad news?4/10

  A

  CCEP's "self-reinvention" is more gradual adaptation (health-orientation, category expansion, regional integration) than a phoenix-like rebirth after disruption; it treats bad news transparently on the whole, honestly clearing the decks with impairments and restructuring, but its DNA is that of a "steady operator" rather than an "innovator who remakes itself in a crisis."

  First, define disruption risk and reinvention DNA. CCEP's core business — bottling and distribution of the cola system within licensed territories — has a relatively low probability of being "wholesale disrupted" by technology; the more realistic threat is chronic erosion: shifting consumer health preferences, sugar taxes, private labels, and energy/coffee substitution. In the face of such chronic erosion, what CCEP displays is continuous adaptability rather than radical reinvention:

  • Category and health-orientation iteration: in its 2024 and 2025 disclosures the company repeatedly stressed low-sugar/no-sugar, pack sizes, and price ladders; in Q1 2026 Coca-Cola Zero Sugar was strong across multiple markets and Energy grew +21.3%. This shows it can follow consumption trends to migrate its portfolio toward zero-sugar, energy, and coffee, but this is "adjusting on the main curve," not "starting over after the core is disrupted."
  • Lacks a reinvention record tested by a life-or-death ordeal: unlike companies that have experienced a collapse of their core business and been forced into a total remake, CCEP has never faced an existential crisis at the business-model level. Its "reinvention DNA" has not been genuinely stress-tested — a point that must be marked down in an honest assessment.

  Now look at "how it treats mistakes and bad news" — on this side CCEP performs positively:

  • Honest clearing rather than concealment: the report notes that in 2024 the company recognized Indonesia impairments, restructuring, and M&A-related items, putting that year's reported operating profit and net profit under pressure; by 2025 reported operating profit recovered to €2.79bn (+31%). Booking the Indonesia asset issue as an impairment rather than hiding it off-balance-sheet is commendable accounting honesty.
  • Bad news disclosed as usual: Indonesia's exposure to a multi-country brand boycott triggered by Middle East events, and volume pressure in parts of Europe, were both directly mentioned in the company's disclosures, without whitewashing.

  But a reservation is also warranted: CCEP's "error handling" is mainly reflected in the discipline of financial clearing, rather than an innovation culture of "fast trial-and-error, self-disruption." It is a steady operator that does its known business solidly and honestly writes down when problems arise.

  Conclusion: on treating bad news — transparent, honest, willing to write down, a positive assessment; on reinvention DNA — only gradual adaptability, lacking verification of remaking itself after disruption, a neutral-to-weak assessment. On this Baillie Gifford dimension, CCEP is a reassuring operator, but not the kind of company that can be reborn from the ashes in a crisis.

  Jun 10, 2026
• QDoes management (especially the founder) have a long-term vision and interests deeply bound to the company? Are they willing to sacrifice current profit for five to ten years out?6/10

  A

  Long-term interest alignment at the equity level is strong (the original bottling family + the Coca-Cola system together hold a controlling stake above half), but CCEP has no "founder" at the helm; management is rational, capital-allocation-friendly, and credit-disciplined, yet they are "credible professional operators" rather than founder-type leaders "willing to sacrifice the present and invest bet-style for ten years out."

  First, answer "whether interests are deeply bound" — this side is a strength, but the subject must be distinguished:

  • Not a founder company: CCEP is the product of a 2016 merger of several Coca-Cola bottlers, and lacks the kind of founder-cum-major-shareholder, personal-vision-driven governance structure Baillie Gifford favors. The question's premise of "especially the founder" does not apply to CCEP, which must be stated honestly.
  • Major shareholders deeply bound to the system (strong): in the ownership structure, Olive Partners holds about 36% and The Coca-Cola Company about 17–19%, and the two together control more than 55% of the voting rights (the report records Olive at 36.1% and TCCC at 19.01%). This means the company is highly bound at the equity level to the original bottling family and the upstream brand owner, so incentive compatibility is broadly decent — major shareholders have strong motivation to run the company steadily for the long term. But this is "major-shareholder binding," a different matter from "management holding large personal stakes"; the report also candidly admits that direct management personal ownership did not form a complete, verifiable summary table in the obtainable materials.

  Now look at "whether long-term vision, whether willing to sacrifice the present for the long term" — the assessment is rational and credible, but not aggressive long-termism:

  • Capital-allocation-friendly and consistent in word and deed: 2025 maintained an about 50% payout, with a full-year dividend of €2.04/share; completed €1bn of buybacks and announced another round of €1bn; shares outstanding fell from 460.95m to 449.09m, and to about 448.65m by mid-2026. Buybacks are real cancellations, not empty talk.
  • Sound credit discipline: alongside large dividends + buybacks, net leverage stayed at about 2.7x (FY2025), with an investment-grade credit rating, without pushing the balance sheet into a dangerous zone to please shareholders.
  • But tilted toward "cash return" rather than "sacrificing the present to bet on the long term": the main theme of CCEP's capital allocation is stable dividends + buybacks + leverage control, the rational play of a mature cash cow, which is precisely not the growth-type posture Baillie Gifford champions of "boldly sacrificing current profit to invest for five to ten years out." Whether M&A (such as the Philippines' US$1.8 billion acquisition, 60% stake) can keep creating high ROIC still needs time to verify.

  Conclusion: interest alignment is strong (via major shareholders rather than founder/management personal ownership), and management is credible, rational, and capital-allocation-friendly — a positive assessment; but its long-termism is "steady stewardship" rather than the "founder betting on the future" type Baillie Gifford favors. This dimension earns a neutral-to-positive assessment, with the highlights in alignment and discipline and the shortfall in the lack of founder-style long-term aggressiveness.

  Jun 10, 2026
• QIf it disappeared tomorrow, how much would customers miss it? Is its growth model sustainable and not reliant on harming society and regulation?5/10

  A

  If it disappeared tomorrow, consumers would hardly miss it (the products are highly substitutable), but retail channels would feel short-term pain (supply, coolers, and execution are hard to backfill instantly) — its "indispensability" is on the channel side, not the consumer side; the growth model is broadly sustainable, but it does carry regulatory friction from sugar taxes, health, and antitrust, and cannot be counted as "zero regulatory risk."

  This Baillie Gifford question requires a double test: ① indispensability, ② whether growth is sustainable and not reliant on harming society and regulation. Answering each honestly.

  ① Indispensability — moderate for channels, low for consumers. The report's component judgment on switching costs is key: low for consumers, moderate for channels. At the consumer level, cola is a strong brand but not irreplaceable — "consumers drink cola because others drink cola, but that is not a typical network effect"; if it truly disappeared, the Pepsi system, private labels, and other beverages could fill in, and consumers would not genuinely miss a particular bottler (what they miss is the "Coca-Cola" brand, and the brand belongs to upstream TCCC rather than CCEP). At the channel level it is different: across 31 markets and about 4 million customers CCEP has on-time supply, shelf merchandising, cooler placement, and point-of-sale execution capabilities, and retailers "cannot easily abandon mature brands, cooler assets, and execution capability" — this is where CCEP is truly missed. So indispensability falls more on the B-side channels than the C-side consumers.

  ② Whether growth is sustainable and does not harm society and regulation — broadly sustainable, but with real regulatory friction. This side must honestly flag the risks:

  • Health/sugar-tax friction: sugary soft drinks long face public-health scrutiny and sugar taxes. The report explicitly notes that the 2025 rise in per-case cost of sales came partly from tax changes in France and the UK; the company's response is to migrate its portfolio toward zero-sugar/low-sugar (Q1 2026 Coca-Cola Zero Sugar strong across multiple markets), a positive signal of adjusting growth toward "more sustainable," but the sugar tax itself is a structural pressure hanging overhead.
  • Antitrust/regulatory events: the report mentions that in 2025 EU antitrust regulators conducted dawn raids on some non-alcoholic beverage companies, and the market once suspected a link to the Coca-Cola bottling system. Such events need not change the business model, but they are enough to prove CCEP is not a "zero-regulatory-risk" consumer blue chip.
  • Packaging and recycling regulation: pack sizes and recycling rules are also continually reshaping the industry.

  Taking both sides together: CCEP's growth is built on a price-increase-plus-penetration model of "selling more, selling dearer, better mix" (2025 reported revenue of €20.9bn, with revenue per case continuing to rise), not on predatory or unsustainable means, and it is actively health-orienting — this is sustainable. But sugar taxes, antitrust, and recycling regulation constitute ongoing regulatory friction costs.

  Conclusion: indispensability concentrates in channel execution (moderate), not consumer loyalty (low); the growth model is sustainable and actively health-orienting, but carries real regulatory friction from sugar taxes and antitrust, and cannot be prettied up as zero risk. On this Baillie Gifford dimension, CCEP is neutral — channel stickiness is a highlight, while consumer substitutability + regulatory friction are demerits.

  Jun 10, 2026
• QWhat are the unit economics of this business (gross margin, incremental returns)? Does it get better or worse as scale grows? Where does the money earned go?5/10

  A

  Unit economics are excellent for the "bottler" species — about 35.6% gross margin, 13.4% operating margin, 11.5% comparable ROIC, and high cash conversion; as scale grows it mainly "improves slowly" by spreading fixed costs rather than in a step change; the money earned is mainly returned to shareholders (dividends + buybacks) with leverage controlled. But its unit-economics ceiling is structurally pressed down by upstream concentrate costs, far short of the brand owner's capital-ultra-light super-profit model.

  First, the absolute level of unit economics (this is CCEP's real strength relative to an ordinary heavy-asset manufacturer):

  • Gross profit and margins: 2025 gross profit of about €7.44bn, gross margin about 35.6%; reported operating profit of €2.79bn, operating margin about 13.4%; net margin about 9.5%. For a bottler that must sustain factories, logistics, cold chain, equipment, and working capital, this is already a fairly healthy level.
  • Incremental returns: 2025 comparable ROIC of 11.5% (11.1% in 2024, only 8.0% in 2021), an improving trend, showing the invested capital is generating decent and rising returns.
  • Cash conversion (core highlight): 2025 operating cash flow of €3.0bn, comparable free cash flow of about €1.84bn, equal to about 93% of net profit (€1.98bn) — the profit is mostly not paper profit but converts into cash at a high ratio, which is key evidence of unit-economics quality.
  • Moderate capital intensity: 2025 PPE purchases of €750m and capitalized software of €200m, with the company-defined capex running at roughly 5% of revenue, higher than brand owner KO but "not high enough to devour cash flow" — a "moderate-capex but steadily-cash-generating" business.

  Does it get better or worse as scale grows? The answer is "slowly better, but not a step change." A local-production share above 90%, scale procurement, and high bottling utilization can spread fixed costs, and Philippine consolidation also brings scale effects — the climb in ROIC from 8.0% to 11.5% partly bears this out. But note: on the cost side, 2025 per-case cost of sales rose (higher concentrate costs, manufacturing-side inflation, France/UK tax changes), so the scale dividend is often partly offset by inflation and upstream costs, and the improvement is mild.

  Where does the money earned go? Mainly returned to shareholders + leverage control: 2025 total returns to shareholders of about €2bn, including €1bn of buybacks and another round of €1bn announced, plus a dividend of €2.04/share (about 50% payout), while net leverage stayed at about 2.7x. This is the rational capital allocation of a mature cash cow, but it also means the money is not mainly directed at high-return new growth but at returns + maintenance investment.

  An honest reminder about the ceiling: the industry's fattest profits sit at the brand and concentrate end, not the bottling end — CCEP still must pay concentrate costs upstream and bear more manufacturing and logistics capital. So although its unit economics are good, they are structurally below the brand owner's layer.

  Conclusion: unit economics are excellent among bottlers, cash conversion is a true highlight, scale brings mild (not step-change) improvement, and the money earned is mainly returned to shareholders — a positive assessment on this dimension; but it is not the layer with the best profit structure, the ceiling is sealed upstream, and it hardly qualifies as "bigger means more super-profit". On this Baillie Gifford dimension, CCEP is at a solid above-average level.

  Jun 10, 2026
• QFor it to rise fivefold in ten years, which conditions must hold simultaneously? Are these conditions realistic? What expectations does today's share price imply?2/10

  A

  A fivefold rise in ten years is almost impossible to hold for CCEP — it would require a set of conditions contrary to the physical characteristics of this mature bottling business to occur simultaneously; and today's share price of about $96.87 implies, precisely, not a "high-speed growth" expectation but the pricing of a "high-quality, steady-cash-flow, stable-return" mature consumer stock — the market is granting a quality premium, not a growth option.

  First, translate "5x in ten years" into hard conditions. Fivefold means a ten-year compound annualized total shareholder return of about 17.5%. For CCEP to achieve it, the following conditions must hold simultaneously:

  1. Double-digit compound earnings growth sustained — but the industry ceiling is only about 6% (the company states the soft-drink category will grow up to about 6% over the next five years), and CCEP's long-term organic growth is low-to-mid single digits (2025 revenue per case +1.6%, reported revenue +2.3% to €20.9bn). Sustaining double-digit compounding via internal growth directly conflicts with the business's physical characteristics.
  2. Substantial valuation-multiple expansion — currently P/E about 19.4, P/FCF about 19.5x, and for a mature bottler to substantially lift its valuation from here lacks a catalyst.
  3. Continuous large M&A with each deal accretive to ROIC — but M&A is a discrete event with real integration risk (the Philippines' follow-through delivery is still to be verified), and one cannot assume multiplying several-fold via M&A for ten consecutive years.
  4. Buybacks continuously offsetting the share count in an undervalued zone — 2025 share count fell from 460.95m to about 448.65m, canceling about 2–3% a year, a drop in the bucket for a fivefold return.

  All four must hold simultaneously to reach a fivefold return, and conditions 1 and 2 basically diverge from reality. So "5x in ten years" is unrealistic — this is not CCEP's odds structure. A better reference is the subjective annualized returns the report gives based on the current price, dividends, buybacks, and growth assumptions: conservative about 4–6%, base about 7–9%, optimistic about 10–12% — even the optimistic scenario falls short of the 17.5% required for a fivefold return.

  What expectations does today's share price imply? Reverse-derived from current data: current price $96.87, market cap about $43.1bn, corresponding to about 19.5x P/FCF, about 19.4x P/E, about 21x conservative owner earnings on the report's basis, about 12.3x EV/EBITDA, and about 4.3x P/B. The market expectation this multiple implies is: a mature high-quality asset with "low-to-mid single-digit steady growth + high cash conversion + stable dividends and buybacks + no valuation compression", and not a "high-speed growth stock." In other words, the market has already priced in most of CCEP's quality premium — it is paying for "visibility and stability," not the option of a "growth burst."

  Layering on the risk-free-rate lens: the current static free-cash-flow yield is about 5.1%, while the 10-year Treasury yield is about 4.6% (on the report's same-day basis), and the static spread shareholders receive is very thin — this further shows the current price is no longer cheap, and the excess return required for a fivefold cannot be safely obtained.

  Conclusion: 5x in ten years requires double-digit compound growth + multiple expansion + continuous accretive M&A all holding simultaneously, which is unrealistic for a mature bottling business with an about-6% ceiling that relies on price increases and penetration; the current $96.87 share price implies the quality premium of a mature high-quality consumer stock, not a growth expectation. This Baillie Gifford dimension is judged weak — CCEP is a good asset, but today's price gives almost no probability of 5x in ten years.

  Jun 10, 2026
• QWhy hasn't the market realized all this yet? Is it that it does not understand, looks down on it, or cannot see far enough? What would become the "narrative inflection point"?3/10

  A

  The market actually "understands it, and has basically got it right" — CCEP is not a misread or undervalued name, but a fairly (even slightly fully) priced high-quality mature bottler; there is no "great growth the market has not yet realized" in the Baillie Gifford sense here, so the real "narrative inflection point" is not value discovery but a better-than-expected change in growth or margins (up or down).

  The implicit premise of this Baillie Gifford question is that "there exists a growth truth the market has not yet realized." For CCEP, the most honest answer is: this premise does not hold. Unpack "does not understand / looks down on it / cannot see far" layer by layer:

  • Does not understand? No. CCEP's business is "simple, transparent, understandable" — "make, move and sell" of cola system beverages across 31 markets, revenue = case volume × revenue per case. This is a business with ample institutional coverage that anyone can understand, with an analyst consensus of "Buy" and a 12-month target price of about $103.93, high coverage, and no cognitive blind spot.
  • Looks down on it? No. Far from looking down on it, the market has granted a quality premium: current price $96.87, P/E about 19.4, P/FCF about 19.5x, and for a mature bottler with reported revenue +2.3%, this is full pricing rather than a disdained undervaluation.
  • Cannot see far? Not really either. CCEP's long-term prospects (low-to-mid single-digit growth, steady cash flow, dividends and buybacks) are highly visible and extrapolable, and the market's judgment of its long-term path matches the fundamentals — which is precisely why it is granted a cash-profit multiple of about 20x.

  So there is no story here of "the market got it wrong, awaiting a fix." CCEP's current share price (having risen to $96.87 from $93.28 on the report date) sits at the upper edge of the fair range, and the static free-cash-flow yield of about 5.1% is only slightly above the 10-year Treasury at about 4.6%, a bland odds structure — this is precisely the mark of "the market has fully priced it," not "has not yet realized."

  Then what would become the narrative inflection point? Since there is no "value-discovery-type" inflection, what can truly change the pricing is a better-than-expected fundamental, and it can go either way:

  • Upside inflection: if structural upgrades such as energy drinks/coffee keep beating expectations (Q1 2026 Energy +21.3%), the Philippines and subsequent M&A significantly boost ROIC, and margins keep expanding, causing the market to re-rate it from a "mature cash cow" to a platform "able to compound at double digits sustainably" — but this requires a qualitative change in business characteristics, and the probability is low.
  • Downside inflection (more to be wary of): if core markets show long-term weak volume and price, margins are eroded by sugar taxes/concentrate costs/inflation, or antitrust or other regulatory events (the report mentions the 2025 EU dawn raids on some non-alcoholic beverage companies) materially weaken regional operating rights, the market could re-price it as a "low-growth, high-leverage consumer stock" (13–15x), at which point a share-price dip to the report's scenario range of €43–50 / about $50–58 is not unimaginable.

  Conclusion: the market does not "fail to understand / look down / see too little"; CCEP is a fairly (slightly fully) priced high-quality mature asset, with no undiscovered growth truth; the narrative inflection comes not from value repair but from a better-than-expected change in growth or margins (upside needs a qualitative business change, downside needs deteriorating fundamentals). This Baillie Gifford dimension is judged weak — its flip side is precisely CCEP's honest positioning: a good company at a fair price, lacking the Baillie Gifford core proposition of "great growth the market has not yet realized."

  Jun 10, 2026